# NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

> **NCT00557011** · PHASE2 · COMPLETED · sponsor: **New River Pharmaceuticals** · enrollment: 52 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DRUG:** NRP104
- **DRUG:** Adderall XR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00557011
- **Lead sponsor:** New River Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557011, "NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00557011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*